Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Allison Whitten Pfizer's LITFULO meets primary endpoints in Phase 3 vitiligo trials Pfizer reported topline results from two Phase 3 trials of LITFULO (ritlecitinib) in nonsegmental vitiligo, with both the 50 and 100 milligram once-daily doses meeting co-primary endpoints for facial and total body repigmentation over placebo at Week 52
SONAR committees and Investigators
Increased Activity and Expression of Histone Deacetylase 1 in Relation to Tumor Necrosis Factor-Alpha in Synovial Tissue of Rheumatoid Arthritis
Therapies: Tricare covers a variety of therapeutic services such as physical therapy, occupational therapy, and speech therapy
The bikini line, underarms, and inner thighs are among the most melanin-reactive areas on the body - not because something is wrong with your skin, but because of the specific conditions these areas endure every single day
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
